Evogene Ltd. has announced a significant cooperation agreement with L.I.A. Pure Capital Ltd. and Invest Pro Shukai Hon Ltd. on October 6, 2026. This agreement aims to resolve outstanding differences between the parties and will result in immediate changes to the board of directors. The move is expected to enhance corporate governance and shareholder engagement within the agricultural chemicals sector.
Prior to the agreement, Dr. Yael Margolin and Mr. Yoshinori Oikawa stepped down from Evogene's board. Following the execution of the cooperation agreement, Dr. Adi Zuluf-Shani and Mr. Oz Adler, both nominees of the Pure Capital Group, were appointed as directors. These changes are set to be confirmed at a general meeting of shareholders scheduled for November 10, 2026.
Evogene, which operates in the agricultural chemicals industry, is listed on the Nasdaq under the ticker EVGN. The company has been navigating a challenging landscape, and this agreement marks a pivotal step in aligning its governance structure with shareholder interests. The cooperation agreement includes provisions for mutual waivers and releases of claims, signaling a fresh start for the company.
Key terms of the cooperation agreement include the immediate appointment of new board members and the withdrawal of a previously proposed special tender offer by the Pure Capital Group. The agreement also establishes a standstill period during which Evogene will not issue new shares or convertible securities, except for routine employee issuances.
The upcoming general meeting will allow shareholders to vote on the election of the new directors and the approval of the cooperation agreement itself. This meeting is seen as a crucial moment for Evogene as it seeks to stabilize its governance and enhance its operational focus.
With the agricultural chemicals sector witnessing increased shareholder activism, Evogene's actions may set a precedent for other companies in the industry. The outcome of the shareholder meeting could influence corporate governance practices across the sector.
The filing does not specify what happens next beyond the scheduled general meeting, but the developments are likely to be closely monitored by investors and industry analysts.